Cedar Pine is a private investment firm that primarily focuses on later-stage direct equity investments in high-growth potential businesses. They strategically target industries such as Deeptech, Wholesale Trade, Retail, non-life science healthcare, and national security/defense, while also maintaining flexibility to invest in other sectors.
100% of their portfolio is in Healthcare. Their most common stage is growth (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 American Pain Consortium | Growth | — | Nov 2023 |
 Digital Diagnostics | Series B | $75M | Aug 2022 |
Top Co-Investors
Last updated: 4 May 2026